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PURPOSE: To review the medical literature regarding the histopathologic and biochemical liver test abnormalities in
chronic asymptomatic or oligosymptomatic alcoholics.
METHODS: Review of articles in the MEDLINE and LILACS databases regarding serum levels and prevalence of
alterations in aspartate-aminotransferase, alanine-aminotransferase, alkaline phosphatase, and total bilirubin, in relation to
liver histopathology, with or without discrimination of types of histopathologic alteration.
RESULTS: Global mean prevalence rates of aspartate-aminotransferase and alanine-aminotransferase alterations were
86.3% and 51.1%; in cases with steatosis they were 79.1% and 38.5%; and in cases of hepatitis, 90.1% and 58%. In all
studies, prevalence rates of aspartate-aminotransferase alterations were significantly higher with lower variability than
those of alanine-aminotransferase. Mean aspartate-aminotransferase levels were higher than 2N (N is the upper normal limit
of the method employed) in all cases with hepatitis histopathology, while those of alanine-aminotransferase were 1.48N, in
the same cases.
Prevalence of alkaline phosphatase and total bilirubin abnormalities were 74.5% and 74.9% globally; in cases of
steatosis, they were 70.9% and 67.9%; and in cases of hepatitis, 75.9% and 77.7%. Mean alkaline phosphatase levels were
above the upper normal limit in all cases, but those of total bilirubin were above normal in 4 of 7 hepatitis studies.
CONCLUSIONS: Prevalence of aspartate-aminotransferase alteration was consistently related to presence of
histopathologic abnormalities; an enzyme level higher than 2N suggests the diagnosis of alcoholic hepatitis.
DESCRIPTORS: Chronic alcoholism. Asymptomatic or oligosymptomatic alcoholics. Liver tests. Liver enzymes and
bilirubin. Histopathology.
Various drugs, including alcohol,
produce metabolic alterations and may
lead to hepatocellular damage through
complex interactive mechanisms.
Hepatocytes submitted to noxious
stimuli may be functionally or struc-
turally damaged, transitorily or perma-
nently, depending on the strength and
duration of the stimuli. Nonetheless,
even structurally damaged liver cells
may be at least partially functional.
Because of this ambiguity, possible
confusion arises regarding structural
damage with functional alteration, es-
pecially when functional tests are al-
tered, which are taken to indicate
structural damage. Non-invasive pre-
sumptive diagnosis of structural dam-
age usually becomes dependent on
quantitative and associated functional
evaluations. In almost all stages, the
various drug-induced alterations of
hepatocytic membranes and organelles
can be accompanied by enzyme altera-
tions and can be observed
histologically1. The liver being the
main organ responsible for drug bi-
otransformation2 may be or not func-
tionally3,4,5 or structurally6,7,8 altered in
chronic alcoholics, and such altera-
tions may be or not followed by clini-




are usually not receptive to undergo-
ing liver biopsy, and performance of
this procedure in them is not easily ac-
ceptable from the ethical perspective.
Furthermore, in clinical practice, uti-
lization of liver biopsies suffers from
various limitations, including the fol-
lowing: biopsies not visually guided
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produce an average of 24% false nega-
tives9; no evidence of necrosis or fibro-
sis was obtained in 40% to 50% of
chronic alcoholics10; biopsies are asso-
ciated with significant morbidity and
with 0.015% to 0.03% mortality
rates11; and other negative factors in-
clude the unnecessary upsetting of pa-
tients and the hospitalization costs.
Consequently, it is difficult to accept
and follow the norm established by the
International Consensus12 of classify-
ing the liver lesions that may occur in
these patients according to the histo-
logic findings.
Liver histologic abnormalities in-
cluding steatosis, hepatitis, and cirrho-
sis that are caused by alcohol are not
mutually exclusive. On the contrary,
each one may be present in the same
case with variable intensity13, repre-
senting a disease continuum14; clini-
cal15,16 and biochemical8,15 alterations
may overlap in the 3 types of his-
topathologic lesions.
Studies of chronic asymptomatic or
oligosymptomatic alcoholics7,17,18 have
revealed enzyme and bilirubin altera-
tions that are sometimes so minor that
it is difficult to interpret their real mean-
ing with regard to whether they indi-
cate the presence of liver damage,
whether they indicate an abnormal liver
test, or whether they indicate a mere
biochemical alteration that is not abnor-
mal. Such ambiguity has led to argu-
ments and even divergent positions
among researchers and specialists19.
A review of the bibliography was
conducted, selecting reports on chronic
oligosymptomatic or asymptomatic al-
coholics containing liver biochemical
and histopathologic evaluations, with
the purpose of exploring conceptual as-
pects and the criteria for interpretation
of biochemical tests. On these bases, we
intended to establish criteria for such
interpretations of enzymes and bilirubin
abnormalities for patients with mild or
sub-clinical symptoms.
MATERIALS   AND   METHODS
A systematic search in the
MEDLINE and LILACS databases was
conducted from 1982 to 2000, in Eng-
lish and neo-Latin languages, employ-
ing the following terms singly or as-
sociated: alcoholism or alcoholic,
oligosymptomatic or asymptomatic or
subclinical, liver disease.
Publications included in this study
referred to asymptomatic patients and
those presenting mild and non-specific
clinical manifestations or sub-clinical
liver disease (oligosymptomatic), and
contained data on prevalence and
types of histopathologic liver altera-
tions and prevalence and levels of
liver enzymes and bilirubin. Excluded
were publications not containing data
on liver histopathology and/or liver
enzymes and bilirubin as well as those
not relating the 2 types of abnormali-
ties. Other comments on such criteria
are indicated in specific cases below.
A total of 14 studies were selected
comprising 1540 patients (1412 males,
128 females) presenting, singly or as-
sociated, data on prevalence of liver
tests alterations, average plasma levels
of liver enzymes and bilirubin, and cor-
relation between prevalence and de-
grees of liver test alterations with liver
histopathology, with or without dis-
crimination of the type of histopatho-
logic alteration. Four of these did not
include data on histopathology4,17,18,20,
5 related the prevalence of liver test ab-
normalities to histopathologic altera-
tions but did not specify the types of
the latter6,7, 21-23; and 5 related the aver-
age serum levels of liver enzymes and
bilirubin to the specific types of his-
topathologic alterations3,24-27. One of the
studies with liver histopathology21 was
excluded because the biochemical al-
terations were not correlated with the
histopathology classes.
Seven studies3,6,22-26 of a total of
847 patients (796 males, 51 females)
were analyzed for evaluation of preva-
lence of liver test alterations accord-
ing to anatomopathologic lesions.
Five studies3,24-27 of a total of 277 pa-
tients (267 males, 10 females) were re-
viewed for correlated elevated serum
levels of biochemical tests and types,
specific or not, with anatomopatho-
logic lesions. Three reports6,22,23 did not
detail the serum levels of liver en-
zymes. From 2 articles24,26, data ex-
pressed as the average and its stand-
ard error were transformed into the av-
erage and the standard deviation.
Statistical comparisons were con-
ducted on qualitative variables,
through the chi-square test, or where
indicated, two-tailed Fisher’s exact
tests. Correlation between variables
was established with Pearson’s coeffi-
cient and significance test. From some
studies, data were displayed as 2 x 2
matrixes and coded, relating the bio-
chemical tests and histopathologic al-
terations as true positive (a), false posi-
tive (b), false negative (c) or true nega-
tive (d). Sensitivity [(a/a+c)100],
specificity [(d/b+d)100], positive [(a/
a+b)100] and negative [(d/c+d)100]
predictive values, all expressed as %,
plus prevalence and proportion of
probabilities (odds; posPP/negPP)
were calculated. The probability of
finding individuals with enzymes and
bilirubin higher than twice the upper
limit of normality was calculated
based on the normal probability curve
[(z~N (0;1)], with the purpose of com-
parison with the Consensus criteria.
The 5% significance level was
adopted.
RESULTS
The prevalence of abnormalities
and the average values of liver en-
zymes and bilirubin, with the respec-
tive reference values, are presented in
tables 1 and 2.
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Table 1 - Prevalence    of    alterations    in    liver   enzymes   in   chronic   asymptomatic   or oligosymptomatic alcoholics
according to the types of histopathologic lesions.
Aspartate- Alanine- Alkaline Total
aminotransferase aminotransferase phosphatase bilirubin
n n % n %  n %  n %
- Liver steatosis
Green3 5    3 60.0 - -  - -     1 20.0
Harinasuta et al.24 157 126 80.0 52 33.0 118 75.0 113 72.0
Nakamura et al. 3 25   19 78.0 18 72.0   11 45.0   13 52.0
Total 148 79.1 70 38.5 129 70.9 129 70.9
- Alcoholic hepatitis
Green3 11 11 100.0 - - 1 9.0
Harinasuta et al.24 100   92 92.0   51 51.0   83 83.0   92 92.0
Helman et al.25 37   34 92.0   13 35.0   22 59.5   35 94.5
Lischner et al.22 135 - -   90 67.4   92 59.0
Mendenhall et al.26 184 161 87.5 118 64.1 150 81.5 142 77.2
Nakamura et al.23 12   12 100.0 11 88.0   10 84.0   10 84.0
Total 310 90.1193       58.0355       75.9 372   77.7
- Various lesions
Bathal et al.6 100 38 38.0  - - - - 28 28.0
Green3 29   9 31.0  - - - -   2 6.9
Nakamura et al.23 52 30 57.0 22 43.0 20 39.0 - -
Total 77 42.5 52 43.0 20 38.5 30 23.9
Table 2 - Values of liver enzymes and total bilirubin in chronic asymptomatic or oligosymptomatic alcoholics according to
the types of  histopathologic lesions.
Aspartate- Alanine- Alkaline Total
aminotransferase aminotransferase phosphatase bilirubin
1 - Liver steatosis
- Green3 (n=5) 56.8 ± 37.0 - - 0.62 ±  0.61
RV   ≤ 40 U/dL - - ≤ 1 mg/dL
2 - Alcoholic hepatitis
- Green3 (n=11) 92.4 ± 30.2 - - 0.61 ± 0.43
RV   ≤ 40 U/dL - - ≤ 1mg/dL
- Harinasuta et al.24 (n = 100) 144 ± 150 56 ± 80 8.6 ± 5 5.7 ± 6
RV   ≤ 40 U   ≤ 38 U   ≤ 4 B U ≤ 1.0 mg/dL
- Helman et al.25 (n = 12) 98 38 21.4 5.7
RV   40 U/mL   35 U/mL   14 KA U ≤ 1.2 mg/dL
- Mendenhall et al.26 (n = 89) 84 ± 56.6 56 ± 56 165 ± 80.2 1.6 ± 0.94
RV 10-40 mU/mL 10-30 mU/mL 40-120 U/mL 0.1-1 mg/dL
3 - Various lesions
- Ryback et al.27 (n = 60) 64.0 ± 71.9 47.2 ± 48.7 84.1 ± 27.8 0.84 ± 0.41
References values 10-40 mU/mL 10-30 mU/mL 40-120 IU/mL 0.1-1 mg/dL
RV = references values; B U = Bodansky units; KA U = King Armstrong units.
I. Aminotransferases
Mean prevalence rates of increases
of aspartate-aminotransferase (AST)
were 458/531 (86.3%) globally, with
148/187 (79.1%, range 60%-80%) in
the steatosis cases and 310/344
(90.1%, range 87%-100%) in alco-
holic hepatitis cases; the difference
between these was not statistically sig-
nificant. For alanine-aminotransferase
(ALT), the prevalence rates of increases
were 263/515 (51.1%) globally, 70/182
(38.5%, range 33%-72%) in the stea-
tosis cases and 193/333 (58%, range
35%-88%) in alcoholic hepatitis cases.
The prevalence rates of AST altera-
tions were always significantly higher
and showed lower variation among the
various studies than those of ALT (Ta-
ble 1). In the study where the types of
histopathologic alterations were not
differentiated, the prevalence rates
were 77/181 (42.5%) for AST and 22/
52 (42.3%) for ALT.
Prevalence of AST abnormality was
significantly higher in cases with than
without histopathologic alteration (P
= 0.002; 95% CI 1.88-184.58; odds ra-
tio 15.75). The relationship between
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Table 3 - Distribution of prevalence of histopathologic lesions and of aspartate-




   n % n % n %
Above the upper reference limit 14 48.8 4 13.8 18 62.6
Inside the normal reference limit   2 6.9 9 31.0 11 37.9
                                         Total 16 55.7 13 44.8 29 100.0
Adapted from Green3. P = 0.002, 95% CI 1.88 to 184.58, odds ratio = 4.28; sensitivity 87.5%;
specificity 69.2%; predictive values: positive 77.8%, negative 81.8%
Table 4 - Ratios between the average liver enzyme and total bilirubin values, and
the upper limit  of normality for the respective test.
Aspartate- Alanine- Alkaline Total
aminotransferase aminotransferase phosphatase bilirubin
1 - Liver steatosis
- Green3 (n = 5) 1.42 - - 0.62
2 - Alcoholic hepatitis
- Green3 (n=11) 2.31 - - 0.61
- Harinasuta et al.24 (n = 100) 3.60 1.47 2.15 5.70
- Helman et al.25 (n = 12) 2.45 1.09 1.53 4.75
- Mendenhall et al.26 (n = 89) 2.10 1.87 1.38 1.60
Average 2.62 1.48 1.69 3.17
3 - Various lesions
- Ryback et al.27 (n = 60) 1.60 1.57 0.70 0.84
prevalence of AST alteration and his-
topathologic damage indicate an
87.5% sensitivity, 77.8% positive pre-
dictive value, and 81.8% negative pre-
dictive value (Table 3).
Mean levels of AST were greater
than 2N (twice the upper limit of nor-
mality) in all cases with histopathol-
ogy of hepatitis, averaging 2.6N (range
2.1N-3.6N), while those of ALT, in the
same cases, were 1.48N (range 1.09N-
1.87N) (Table 4).
II. Alkaline phosphatase
In studies with defined histopatho-
logic examinations, prevalence of al-
kaline phosphatase (AP) increases
were 484/650 (74.5%) globally, 129/
182 (70.9%, range 45%-75%) in cases
of steatosis, and 355/468 (75.9%,
range 59.5%-84%) in cases of hepati-
tis. Where histopathologic abnormali-
ties were not differentiated, altered AP
prevalence was 20/52 (39%).
In all cases of hepatitis, average AP
levels were above the upper normal
level, which was not observed where
patients had the histopathologic types
of lesions not differentiated. An aver-
age above 2N was reported in only 1
of the studies of alcoholic hepatitis
patients (Table 4).
III. Total bilirubin
Prevalence of bilirubin alterations
in studies with defined histopatho-
logic data were 499/666 (74.9%) glo-
bally, with 127/187 (67.9%, range
20%-72%) in steatosis cases and 372/
479 (77.7%, range 9%-94.5%) in cases
of alcoholic hepatitis. Where the type
of histopathologic alteration was not
defined, prevalence was 30/139
(23.3%, range 6.9%-28%).
In 4 studies on patients with alco-
holic hepatitis, the average of total bi-
lirubin (TB) was above normal, but
was above 2N only in 3 of them. In
one study of patients with steatosis
and hepatitis, and in another where the
types of lesions was not differentiated,
the average value was below the up-
per limit of normality (Table 4).
IV. Association of enzymes and
bilirubin alterations
Patients presenting 1 or more bio-
chemical abnormality in liver tests
(AST, ALT, AP, TB) showed a signifi-
cantly higher prevalence of histopatho-
logic alteration than those with normal
tests (P = 0.001; 95% CI range 1.99-
20.31; odds ratio 5.78). Under these
criteria, sensitivity was low (49.1%),
but the positive predictive value was
high (91.4%) (Table 5).
Comparing results from tables 3
and 5, it can be concluded that con-
sidering only the aminotransferases in-
creases related to presence of his-
topathologic alteration, irrespective of
type, there is a gain in sensitivity and
negative predictive value but a loss in
specificity. The probability of diag-
nosing liver damage is increased when
other alterations are considered, in-
cluding any of the aminotransferases
plus AP and TB (Tables 3 and 5).
The low probability of occurrence
of liver enzymes and bilirubin values
above 2N (Table 6) was noticeable.
COMMENTS
A biochemical survey of asympto-
matic residents of the USA detected
about 6% with abnormal levels of liver
enzymes, while the prevalence of liver
disease in the general population was
significantly lower (about 1%)28. In
routine examinations of Canadians,
about 10% showed at least 1 abnormal
liver biochemical test29.
In studies with liver histopathology,
25%-35% of chronic alcoholics with
mild or no clinical manifestation of
hepatopathy were considered free of
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Table 5 - Distribution of prevalence of histopathologic lesions and biochemical
alterations in chronic oligosymptomatic and asymptomatic alcoholics.
Biochemical data Histopathology
Altered Normal Total
   n % n % n %
One or more abnormalities   53 37.1 5 3.5 58 40.5
No abnormality   55 38.5 30 20.9 85 59.5
                                          Total 108 75.6 35 24.4 143 100.0
Data from Bruguera et al.7, on Aspartate-aminotransferase, Alanine-aminotransferase, Alkaline
phosphatase, and Total bilirubin, in HBsAg negative and without history of viral hepatitis
patients. P = 0.001, 95% CI 1.99 to 20.31, odds ratio = 5.78; sensitivity 49.1%; specificity
85.7%; predictive values: positive 91.4%, negative  35.3%
Table 6 - Frequency  of  occurrence  of  liver enzymes and total bilirubin values
higher  than   the   upper   limit   of   normality    in   chronic   asymptomatic  or
oligosymptomatic alcoholics.
Aspartate- Alanine- Alkaline Total
aminotransferase aminotransferase phosphatase bilirubin
1 - Liver steatosis
- Green 3 (n = 5) 26.4 - -   1.2
2 - Alcoholic hepatitis
- Green 3 (n = 11) 65.9 - -   6.2
- Harinasuta et al.24 (n = 100) 66.6 40.1 54.8 26.8
- Mendenhall et al.26 (n = 89) 52.8 47.2 17.6 33.4
Average 61.8 43.7 36.2  22.1
3 - Various alterations
- Ryback et al.27          (n = 60) 41.3 39.7 0   2.3
All values in %.
hydes39,40, some of these in amounts
higher than the allowed limits, which
could act synergistically with alcohol
in producing liver disease. Excessive
and prolonged ingestion of beverages
containing high iron contents could
lead to elevations in blood iron con-
centrations which is associated with
significantly elevated average plasma
levels of AST, ALT, and AP18; the high
(close to 100%33) prevalence of under-
nutrition in alcoholics with alcoholic
hepatitis due to both proteic and ca-
loric deficiency resulting from low in-
gestion and inadequate utilization of
nutrients absorbed41; and biochemical
and histologic abnormalities resulting
from variations in abstinence periods
before blood sampling or obtaining
biopsies6, as well as in different alco-
holism regimes, with respect to time
and amount of the habit. When pa-
tients look for assistance due to com-
plications resulting from the alcoholic
state or just for treatment of the alco-
holism, they might comprise selected
samples that would create at least par-
tial differences in the incidence of
types and severity of structural liver
lesions6 as well as in the prevalence of
alterations of some types of liver en-
zyme activity3,26 (for example, a pro-
portion of alcoholics showed slight
spontaneous elevation of the activity
of aminotransferases soon after alcohol
withdrawal42). In addition to these fac-
tors, genetic conditions and individual
susceptibility may affect the develop-
ment of alcoholic liver disease15,43.
Among the various series studied,
independently of whether patients were
symptomatic or not, the prevalence
rates of steatosis varied from 50% to
55% and that of alcoholic hepatitis
from 8% to 63%32. In a Brazilian study,
histopathologic alterations were de-
tected in 67.9%, being milder (steato-
sis, reactional or grades I and II steato-
hepatitis) in 26.8% and more severe
(steato-hepatitis grades III and IV) in
41.1%30.
liver disease7,30,31. In the present study, in
the same category of patients, biochemi-
cal liver tests indicated 31% (range
21%-40%) free from liver disease.
The variations observed in
oligosymptomatic or asymptomatic al-
coholics among studies of prevalence
rates of enzyme increases, which were
relatively modest with respect to AST,
as well as of histologic abnormalities,
could be due to various conditions
and peculiarities. These include the
different sex ratios in the samples,
women being more susceptible to al-
coholic liver damage32; morphologic
identification of classic alcoholic
hepatitis being difficult in cases with
massive adipose deposition, as well as
the distribution of adipose tissue not
being uniformly distributed in the
liver33; the 3 types of liver morpho-
logic alterations-steatosis, hepatitis,
and cirrhosis-possibly being present or
distributed with different intensities in
the same case13; infection by C- type
virus that may act synergistically in
liver damage, provoking a more ag-
gressive course of the alcoholic hepa-
titis34,35 with elevation of serum levels
of both aminotransferases36, especially
ALT37; tobacco-smoking alcoholics
showing higher AST levels (with
higher AST/ALT ratios) and also of AP
levels, relative to non-smokers, sug-
gesting synergism between alcohol
and tobacco in liver damage38; the al-
coholic beverage most utilized by Bra-
zilian alcoholics being sugarcane
spirit, which contains a chemical com-
position qualitatively different from
those of other fermented and distilled
beverages most utilized in other coun-
tries. It contains minerals (iron and
copper), upper alcohols, and alde-
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The behavior of each of the en-
zymes and bilirubin, as well as the
correlation between biochemical ab-
normalities and liver histopathology is
detailed below.
1. Aminotransferases
In this review, among all enzymes,
the prevalence of alteration in AST, es-
pecially in patients with alcoholic
hepatitis, was the highest and most
uniform across all series. AST abnor-
mality was directly correlated with the
presence of histopathologic liver al-
terations. The fact that the test for AST
had high sensitivity demonstrates its
capability for indicating liver damage
in alcoholics; additionally, its high
positive and negative predictive val-
ues allow the differentiation with high
probability of individuals with and
without liver disease.
Our conclusions regarding the
behavior of AST do not agree with
those of Rosman and Lieber44 when
they state that activities of liver en-
zymes, including AST, have limited di-
agnostic usefulness in predicting the
histologic staging. These authors have
generalized the results of Li et al.45 to
all types of histologic lesions; these re-
sults indicate the limitations of the en-
zyme values only for identification of
liver fibrosis (perivenular fibrosis, sep-
tal fibrosis, and incipient cirrhosis) and
for accurately discriminating liver fi-
brosis from non-complicated steatosis.
We found that detection of serum
AST levels higher than twice the up-
per normal limits, irrespective of the
reference values in each procedure,
was correlated with high probability of
alcoholic hepatitis. In another study13,
it was observed that the AST levels
were correlated among alcoholics di-
rectly and exclusively with the pres-
ence and extent of hepatocellular
necrosis.
Prevalence of altered levels and
average values of ALT varied widely
in both categories of steatosis and al-
coholic hepatitis, confirming that this
enzyme was not an adequate test for
liver alterations in alcoholics.
The generally low values of
aminotransferases in alcoholic hepati-
tis, relative to viral hepatitis and le-
sions caused by other types of drugs,
could be consequent to pyridoxine de-
ficiency, which occurs in chronic alco-
holics at high frequency43, as well as
to the slow course of hepatocellular
necrosis resulting from alcohol con-
sumption and undernutrition. This
contrasts with the acute cell lesions
following viral infections or toxin in-
gestion, where there is quick release of
great amounts of enzymes into the cir-
culation 13.
2. Alkaline phosphatase
In chronic alcoholics, AP altera-
tions are related more closely to dis-
turbances in the free flow in biliary
routes, while those of gamma-
glutamyltransferase (GGT) would indi-
cate liver enzymatic induction and
hepatocellular damage46 or difficulties
in biliary excretion47. Therefore in al-
coholics, AP alterations are more sig-
nificant than those of GGT. AP activ-
ity is elevated when cholestatic proc-
esses are present48. Elevation in AP is
detected in liver steatosis and in alco-
holic hepatitis in a frequency of about
2/3 of the cases.
Elevation in AP, especially in the
absence of cholestasis signs, is sugges-
tive of alcoholic hepatitis15. In this sur-
vey, we observed that in studies where
alcoholic hepatitis was the fundamen-
tal lesion, AP was always elevated.
3. Bilirubin
Total bilirubin abnormalities in
chronic alcoholics may result from
isolated or combined increases of the
non-conjugated and conjugated frac-
tions. An increase in the conjugated
fraction always denotes hepatocyte
damage15. Elevation of the non-conju-
gated fraction may result from various
causes, including increased absorption
from enterohepatic pools for reasons
that are not entirely clear49,50; deficient
uptake and conjugation by the liver,
similar to Gilbert’s syndrome51; in-
creased back flow of unaltered non-
conjugated bilirubin to the plasma af-
ter having been taken up by the liver
in a first passing due to reduced intra-
cellular glutathione52; functional and
structural alterations in hepatocyte
organelles and plasmatic membranes
due to lipid peroxidation32; hemolysis
due to hypersplenism secondary to
liver disease; and hyperlipidemia re-
sulting from low activity of serum li-
poprotein lipase in patients with alco-
holic hepatitis15,48. Hypertriglyceri-
demia was observed in 56% of oligo-
symptomatic or asymptomatic chronic
alcoholics53.
Serum bilirubin levels were best
correlated with the severity of alco-
holic hepatitis54.
4. Associated abnormalities
A recent publication analyzing re-
sults of liver laboratory tests con-
cluded that such exams are of limited
usefulness due to insufficient sensitiv-
ity or specificity55. Nevertheless, care-
ful reading of the article leads to the
conclusion that the authors were gen-
eralizing from observations on viral
hepatopathies.
In alcoholism, the probability of
diagnosing liver damage was in-
creased when abnormalities of ALT,
AP, and TB were considered in asso-
ciation with those of AST7. This in-
creased probability was significantly
reduced when the criteria for altered
tests adopted the 2N cut-off limit of
values.
Results in this review confirm the
previous conclusion29 that in cases of
alcoholics with alcoholic hepatitis,
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there are high frequencies of abnor-
malities in AST, AP, and TB. A conjunc-
tion of elevated bilirubin serum level,
increased AP activity, leucocytosis, and
increased erythrocyte sedimentation
rate is suggestive of alcoholic hepati-
tis15. Association of enzyme abnormali-
ties with other biochemical evidence of
liver dysfunction (bilirubin, albumin, or
prothrombin activity) indicates ad-
vanced liver disease and functional im-
pairment of the organ29.
Associated concerted elevations of
one of the aminotransferases and of AP
would favor diagnosis of cholestatic
more than the hepatocellular types of
liver disease. The latter type would be
considered singly only when elevation
of the aminotransferases was twice or
more than that of AP29.
Probabilities of occurrence of 2N
enzyme values in the presence of his-
topathologic alterations were very low,
and adoption of such criteria for con-
sidering the results abnormal could
have caused biases in studies56 at-
tempting to investigate the occurrence
of abnormal tests in specific groups or
in the general population, neglecting
alcoholic conditions.
CONCLUSIONS
Prevalence of increases in AST3 was
consistently related to the presence of
histopathologic abnormalities and el-
evated levels of the enzyme; higher
than twice the upper limit of normal-
ity of the determination method indi-
cating the diagnosis of alcoholic hepa-
titis. The possibility of recognizing al-
coholic hepatitis through laboratory
tests in patients with mild or no symp-
toms should be an important goal that
would be useful for at least 2 reasons:
it would allow therapeutic interven-
tion32,57 and it would make preventive
measures possible58,59, with the purpose
of avoiding evolution to more severe
forms of liver disease48.
The probability of diagnosing
liver disease in alcoholics increased
when associated abnormalities of
aminotransferases, alkaline phos-
phatase, and bilirubin were considered.
While there is no uniformity in
definitions, it can be concluded for
practical purposes that values equal
to, or below 2N or 3N, between 3N and
20N, or higher than 20N, for
aminotransferases, and equal to, or be-
low 1.5N or 2N, between 2N and 5N,
and higher than 5N, for alkaline phos-
phatase, would be considered, respec-
tively mild, moderate, and strong el-
evations60. Adoption of such criteria in
analysis of results in this review indi-
cated that in alcoholics, irrespective of
the type of liver lesion, enzyme in-
creases should be considered mild.
Nevertheless, the probability of diag-
nosing liver disease in alcoholics was
increased when associated increases of
aminotransferases, alkaline phos-
phatase, and bilirubin were considered,
irrespective of their levels.
Therefore, the generalization of cri-
teria and terminology established by
the International Consensus12 (that is,
defining the label of liver damage as
when increases of ALT and TB are
higher than 2N; biochemical abnor-
malities as when isolated increases of
AST, AP, or TB are higher than 2N; and
liver test abnormality as when increases
in ALT, AST, AP, and TB are between N
and 2N) have not been backed by data
in this review on alcoholics with mild
or no clinical manifestation or with his-
topathologic lesions considered mild.
Were such strict criteria applied to al-
coholics, one would be misled and risk
not being able to identify occurrences
of liver damage. Missed diagnoses
could be construed as negligent
behavior towards the therapeutic and
preventive missions.
In the majority of studies attempt-
ing to evaluate the occurrence of liver
disease in the general population, one
of the parameters considered to be of
value is the alteration of ALT, the en-
zyme thought to be the most sensitive
and specific indicator for detecting
hepatocellular damage. Considering
that an average of about 10% of
populations are alcoholics61 (between
3% and 20% in Latin America62), and
that in alcoholism the most frequently
altered enzyme is AST, it can be said
that the choice between the two
aminotransferases may constitute an
important factor of statistical bias.
More than a proposition for spe-
cific terminological attribution to al-
terations in complementary clinical
exams, this study points to the need for
revision of generalizations and estab-
lished concepts regarding liver en-
zyme tests in chronic alcoholics with
mild or no clinical manifestation.
A more detailed study of other
methodologic aspects and a qualitative
evaluation of the heterogeneity in the
samples reported in the reviewed bib-
liography, as well as a possible expan-
sion of the searches, should improve
the present state of knowledge.
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RESUMO
70,9% e 67,9% nos casos de esteatose
e 75,9% e 77,7% nos casos de hepati-
te, respectivamente. Em todos os casos
de hepatite, os níveis médios da
fosfatase alcalina estavam acima do li-
mite superior da normalidade. Em 4 de
7 estudos sobre pacientes com hepati-
te a média da bilirrubina total estava
acima do normal.
CONCLUSÕES: As prevalências
de alterações da aspartato-aminotrans-
ferase foram consistentemente relacio-
nadas a presença de alterações histopa-
tológicas e o nível elevado da enzima,
maior que 2N do método de determi-
nação, sugere o diagnóstico de hepa-
tite alcoólica.
DESCRITORES: Alcoolismo crô-
nico. Alcoolistas assintomáticos ou
oligossintomáticos. Testes hepáticos.
Enzimas hepáticas e bilirrubina.
Histopatologia.
BORINI P e col. - Alterações histopato-
lógicas e testes bioquímicos hepá-
ticos em alcoolistas crônicos
assintomáticos ou oligossinto-
máticos: uma revisão. Rev. Hosp.
Clín. Fac. Med. S. Paulo 58(3):
147-156, 2003.
OBJETIVO: Revisar a literatura
médica referente às relações entre al-
terações histopatológicas e testes
bioquímicos hepáticos em alcoolistas
crônicos assintomáticos ou oligossin-
tomáticos.
MÉTODOS: Levantamento, a par-
tir das bases de dados MEDLINE e
LILACS e referências em publicações,
das prevalências de alterações e níveis
séricos da aspartato-aminotransferase,
alanino-aminotransferase, fosfatase al-
calina e bilirrubina total relacionados
com a histopatologia hepática, com e
sem discriminação do tipo de alteração
histopatológica.
RESULTADOS: As taxas médias das
prevalências da aspartato-aminotrans-
ferase e alanino-aminotransferase foram
86,3% e 51,1% globalmente, sendo
79,1% e 38,5% nos casos de esteatose
e 90,1% e 58% nos casos de hepatite,
respectivamente. As taxas das preva-
lências das alterações da aspartato-
aminotransferase foram, em todos os es-
tudos, significativamente mais altas e
mostraram menores variações que aque-
las da alanino-aminotransferase. Os ní-
veis médios da aspartato-aminotrans-
ferase foram maiores que 2N (duas ve-
zes superior o limite superior da norma-
lidade) em todos os casos com histo-
patologia de hepatite, enquanto que os
da alanino-aminotransferase, nos mes-
mos casos, foram 1,48N.
As prevalências de alterações da
fosfatase alcalina e bilirrubina total fo-
ram 74,5% e 74,9% globalmente,
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